Opportunity Information: Apply for CDC RFA DP16 1602
The Centers for Disease Control and Prevention (CDC), through its National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), released this FY16 cooperative agreement funding opportunity to strengthen epilepsy-related programs, services, and outcomes by working through national partnerships. The opportunity recognizes epilepsy as a chronic neurological condition involving recurrent seizures, affecting an estimated 2.9 million people in the United States with active epilepsy (meaning physician-diagnosed epilepsy that is currently being treated or includes at least one seizure in the past year). The CDC frames epilepsy not only as a medical issue, but also as a major public health and equity issue, since people with epilepsy often have multiple other chronic conditions, are more likely to live in lower-income households, report disability at higher rates, and experience reduced health-related quality of life. The burden is also economic, with epilepsy associated with an estimated $15.5 billion each year in medical costs plus lost or reduced earnings and productivity.
A major problem highlighted in the announcement is the gap between need and appropriate clinical care. Using 2010 National Health Interview Survey findings, CDC notes that only 57.7% of adults with epilepsy and uncontrolled seizures received appropriate care in the sense of seeing a neurologist or epilepsy specialist. The CDC links delayed recognition of seizures and inadequate treatment to serious consequences such as continued seizures, injuries, disability, possible brain damage, and increased risk of early death. In other words, the FOA is motivated by the idea that better-connected systems, better-trained providers, and stronger community supports can change real outcomes for people living with a complex condition.
The announcement also stresses that epilepsy remains widely recognized but poorly understood, even among people who personally know someone with epilepsy. While overt negative stereotypes have declined over time, CDC points out that many people still do not know basic seizure first aid and often report fear and safety concerns about being around someone who has seizures. That lack of understanding fuels stigma, which can isolate people with epilepsy and limit participation in everyday life such as school, work, and community activities. Because of this, the FOA treats public education and stigma reduction as central outcome areas rather than optional add-ons.
The opportunity is closely tied to the Institute of Medicine (IOM) 2012 report, "Epilepsy Across the Spectrum: Promoting Health and Understanding," which documented national gaps and proposed 13 recommendations for action. CDC indicates it has a key role in 12 of those recommendations, including improving education for health professionals, improving the delivery and coordination of community services, engaging media to increase accurate awareness and reduce stigma, and expanding education for people with epilepsy and their families. The FOA reflects that roadmap and was also shaped by feedback gathered from more than a dozen stakeholder groups during the agency's engagement process, signaling that CDC expects a broad, partnership-driven approach rather than isolated projects.
Programmatically, the FOA supports three core public health functions applied to epilepsy: building workforce competency (so professionals and systems are better prepared to respond to epilepsy-related needs), mobilizing community partnerships and actions (so services and supports are coordinated and accessible), and educating and empowering people about epilepsy (so individuals, families, and the public have practical knowledge, confidence, and tools). These functions are intended to work together, with national partners acting as catalysts that can influence practice, service delivery, and public understanding at scale.
The long-term goals described are concrete and outcome-oriented: increasing the number of people with epilepsy who receive appropriate and timely medical care; improving social participation such as employment and school attendance; decreasing public stigma; and ultimately improving health and quality of life for people with epilepsy. The funding mechanism is a discretionary cooperative agreement, meaning CDC expects to have substantial involvement with awardees in shaping, monitoring, and supporting the work rather than simply issuing funds with minimal interaction.
Key administrative details include the funding opportunity title "Improving Epilepsy Programs, Services, and Outcomes through National Partnerships," funding opportunity number CDC-RFA-DP16-1602, and CFDA number 93.850. Eligibility is listed as unrestricted, which generally means a wide range of organizations may apply if they can meet the program and administrative requirements. The original application closing date was April 7, 2016. CDC anticipated making 2 awards, with an award ceiling of $4,000,000, indicating large, nationally oriented projects designed to influence systems, partnerships, and public impact rather than small local demonstrations.Apply for CDC RFA DP16 1602
- The Centers for Disease Control - NCCDPHP in the health sector is offering a public funding opportunity titled "Improving Epilepsy Programs, Services, and Outcomes through National Partnerships" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.850.
- This funding opportunity was created on 2015-12-03.
- Applicants must submit their applications by 2016-04-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $4,000,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is this funding opportunity?
This is a CDC (Centers for Disease Control and Prevention) FY16 cooperative agreement funding opportunity titled "Improving Epilepsy Programs, Services, and Outcomes through National Partnerships". It is administered through CDC's National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) and is designed to strengthen epilepsy-related programs, services, and outcomes by working through national partnerships.
2) Who is the sponsor and which CDC center is involved?
The sponsor is the Centers for Disease Control and Prevention (CDC), and the work is routed through the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP).
3) What is the funding mechanism and what does it imply for applicants?
The mechanism is a discretionary cooperative agreement. This means CDC expects substantial involvement with the awardees in shaping, monitoring, and supporting the work, rather than simply providing funds with minimal interaction.
4) What problem is CDC trying to address through this opportunity?
The announcement highlights a major gap between the need for care and the care people actually receive. Using 2010 National Health Interview Survey findings, CDC notes that only 57.7% of adults with epilepsy and uncontrolled seizures received "appropriate care" in the sense of seeing a neurologist or epilepsy specialist. The FOA links delayed recognition of seizures and inadequate treatment to continued seizures, injuries, disability, possible brain damage, and increased risk of early death.
5) How does CDC frame epilepsy in this opportunity?
CDC frames epilepsy not only as a medical issue, but also as a major public health and equity issue. The FOA points out that people with epilepsy often have multiple chronic conditions, are more likely to live in lower-income households, report disability at higher rates, and experience reduced health-related quality of life.
6) How many people are affected by epilepsy according to the opportunity?
The opportunity cites an estimate of 2.9 million people in the United States with active epilepsy.
7) What does "active epilepsy" mean in this announcement?
"Active epilepsy" is described as physician-diagnosed epilepsy that is currently being treated or includes at least one seizure in the past year.
8) Why does the announcement emphasize public understanding and stigma reduction?
The FOA states that epilepsy remains widely recognized but poorly understood, even among people who know someone with epilepsy. Many people do not know basic seizure first aid and report fear and safety concerns about being around someone who has seizures. This lack of understanding fuels stigma that can isolate people with epilepsy and limit participation in school, work, and community life. Because of that, the FOA treats public education and stigma reduction as central outcomes.
9) What is the economic burden of epilepsy cited in the FOA?
The announcement states epilepsy is associated with an estimated $15.5 billion each year in medical costs plus lost or reduced earnings and productivity.
10) What national roadmap or report is this opportunity tied to?
The FOA is closely tied to the Institute of Medicine (IOM) 2012 report, "Epilepsy Across the Spectrum: Promoting Health and Understanding", which documented national gaps and proposed 13 recommendations for action.
11) How does CDC position its role relative to the IOM recommendations?
CDC indicates it has a key role in 12 of the 13 IOM recommendations. Examples mentioned in the announcement include improving education for health professionals, improving delivery and coordination of community services, engaging media to increase accurate awareness and reduce stigma, and expanding education for people with epilepsy and their families.
12) What kind of approach does CDC expect from applicants?
The FOA signals a broad, partnership-driven approach rather than isolated projects. It states the opportunity was shaped by feedback gathered from more than a dozen stakeholder groups and emphasizes working through national partnerships to influence systems, services, and public understanding at scale.
13) What are the three core public health functions supported by this FOA?
The FOA supports three core functions applied to epilepsy:
- Building workforce competency (so professionals and systems are better prepared to respond to epilepsy-related needs)
- Mobilizing community partnerships and actions (so services and supports are coordinated and accessible)
- Educating and empowering people about epilepsy (so individuals, families, and the public have practical knowledge, confidence, and tools)
14) How are the three core functions intended to work together?
The FOA describes these functions as mutually reinforcing. National partners are expected to act as catalysts that can influence practice, service delivery, and public understanding at scale, rather than operating as separate, disconnected activities.
15) What long-term goals or outcomes are named in the announcement?
The long-term goals described include:
- Increasing the number of people with epilepsy who receive appropriate and timely medical care
- Improving social participation, such as employment and school attendance
- Decreasing public stigma
- Improving health and quality of life for people with epilepsy
16) What does the FOA consider "appropriate care" for adults with uncontrolled seizures (as cited)?
In the cited 2010 National Health Interview Survey finding, "appropriate care" is described as seeing a neurologist or epilepsy specialist for adults with epilepsy and uncontrolled seizures.
17) What types of consequences does CDC associate with delayed recognition of seizures or inadequate treatment?
The announcement connects delayed recognition and inadequate treatment to continued seizures, injuries, disability, possible brain damage, and an increased risk of early death.
18) What is the funding opportunity number and CFDA number?
The funding opportunity number is CDC-RFA-DP16-1602, and the CFDA number is 93.850.
19) What is the eligibility for this opportunity?
Eligibility is listed as unrestricted, which generally implies a wide range of organizations may apply if they can meet program and administrative requirements.
20) When was the original application closing date?
The original application closing date listed in the announcement was April 7, 2016.
21) How many awards did CDC anticipate making under this FOA?
CDC anticipated making 2 awards.
22) What is the award ceiling and what does that suggest about project scope?
The award ceiling is $4,000,000. Combined with the emphasis on national partnerships and system-level influence, this suggests the FOA is aimed at large, nationally oriented projects designed to affect services, partnerships, and public impact rather than small local demonstration efforts.
23) Why does this opportunity emphasize national partnerships instead of local-only programs?
The FOA focuses on national partnerships because CDC is aiming for broad impact: improving practice, strengthening service coordination, and changing public understanding and stigma at scale. The opportunity describes national partners as catalysts that can influence systems and outcomes beyond a single community.
Browse more opportunities from the same category: Health
Next opportunity: Tobacco Regulatory Science (R01)
Previous opportunity: Building Capacity of Nigerian Law Enforcement Explosive Ordinance Management
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP16 1602
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP16 1602) also looked into and applied for these:
| Funding Opportunity |
|---|
| Reinforcing Capacity at Two Centers of Excellence to Sustain the Delivery of Comprehensive HIV Clinical Services in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1680 Funding Number: CDC RFA GH16 1680 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
| Strengthening Health Management Information Systems, Data Use and Data Quality in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1674 Funding Number: CDC RFA GH16 1674 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $1,500,000 |
| Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE): Study to Explore Early Development (SEED) 3 Apply for RFA DD 16 001 Funding Number: RFA DD 16 001 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $800,000 |
| Technical Assistance to Host Country Public Health Institutions in Tanzania to Lead HIV Response and Develop and Sustain Systems Required to Achieve and Sustain HIV Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1650 Funding Number: CDC RFA GH16 1650 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $1,159,375 |
| Building Capacity to Deliver High Quality HIV Prevention, Care and Treatment Services for Key Populations and People Living with HIV in the Caribbean Region under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1607 Funding Number: CDC RFA GH16 1607 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $1,036,000 |
| HIV Surveillance for Epidemic Control in Malawi under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1629 Funding Number: CDC RFA GH16 1629 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $700,000 |
| Assisting the Ministry of Health and Social Services (MOHSS) in Providing Critical Human Resources for Health to Achieve HIV Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1640 Funding Number: CDC RFA GH16 1640 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $8,867,471 |
| Prevention of Healthcare-Associated Tuberculosis Infection in Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1673 Funding Number: CDC RFA GH16 1673 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $1,500,000 |
| Strengthening the HIV Services Quality Improvement and Quality Management Systems of the Ethiopian Federal Ministry of Health, Regional Health Bureaus, and Public Health Facilities under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1614 Funding Number: CDC RFA GH16 1614 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $1,000,000 |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Central Region and Laikipia County of the Republic of Kenya under the President’s Emergency Plan for A Apply for CDC RFA GH16 1700 Funding Number: CDC RFA GH16 1700 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Supporting Implementation of Comprehensive HIV Prevention, Care and Treatment Programs in Bomu Hospital Affiliated Sites, Coptic Hospitals, and Faith-Based Sites in the Eastern Slums of Nairobi, Kenya under the President’s Emergency Plan for AI Apply for CDC RFA GH16 1690 Funding Number: CDC RFA GH16 1690 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $18,500,000 |
| Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in Nairobi, Central, and Eastern Regions of the Republic of Kenya under the President Apply for CDC RFA GH16 1717 Funding Number: CDC RFA GH16 1717 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President&# Apply for CDC RFA GH16 1716 Funding Number: CDC RFA GH16 1716 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $14,000,000 |
| PPHF 2016 – Immunization - Immunization and Vaccines for Children Program – Financed in Part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP13 130104PPHF16 Funding Number: CDC RFA IP13 130104PPHF16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National Syndromic Surveillance Program Community of Practice Apply for CDC RFA OE16 1601 Funding Number: CDC RFA OE16 1601 Agency: Centers for Disease Control - CSELS Category: Health Funding Amount: $400,000 |
| Core State Violence and Injury Prevention Program (Core SVIPP) Apply for CDC RFA CE16 1602 Funding Number: CDC RFA CE16 1602 Agency: Centers for Disease Control - NCIPC Category: Health Funding Amount: $475,000 |
| Building Sustainable Laboratory Quality Systems in Cote d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1612 Funding Number: CDC RFA GH16 1612 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
| Strengthening the Strategic Information Capacity of the Ministry of Health (MOH) in Support of HIV/AIDS Prevention, Care and Treatment Activities in the Democratic Republic of Congo under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1613 Funding Number: CDC RFA GH16 1613 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $1,000,000 |
| Advanced Education Nursing Traineeship (AENT) Program Apply for HRSA 16 071 Funding Number: HRSA 16 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Johnston County Osteoarthritis Project: Arthritis, Disability, and Other Chronic Diseases Apply for RFA DP 16 003 Funding Number: RFA DP 16 003 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP16 1602", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.